TORONTO, Feb. 27, 2014 /CNW/ - A Canadian-led ground-breaking study into the prevention of colon cancer recurrence could potentially change the way cancer is treated by adding exercise to standard treatments. But more colon cancer survivors are needed to participate in a long-term clinical trial called CHALLENGE. As core funder of the study, the Canadian Cancer Society is promoting the opportunity for eligible colon cancer survivors to participate in the clinical trial and contribute to improved survival and better quality of life for future patients.
|What:||Photo and interview opportunity with the lead investigator and participants in the CHALLENGE clinical trial|
|When:||Monday, March 3, 10 am - 11:30 am|
|Who:||Dr Chris Booth, lead researcher, oncologist, Kingston General Hospital|
|Dr Sian Bevan, Director of Research, Canadian Cancer Society|
|Martin Kabat, CEO, Canadian Cancer Society, Ontario Division|
|Colon cancer survivors and participants in the CHALLENGE trial|
|Where:||Ground floor meeting room, 55 St. Clair Ave West, Toronto|
|Photo op:||Two participants will be on hand to exercise on a treadmill, as well as to talk about their cancer experience and why they are participating in the clinical trial.|
About the Canadian Cancer Society
The Canadian Cancer Society is a national, community-based organization of volunteers whose mission is to eradicate cancer and enhance the quality of life of people living with cancer. Thanks to our donors and volunteers, the Society has the most impact, against the most cancers, in the most communities in Canada. Building on our progress, we are working with Canadians to change cancer forever. For more information, visit cancer.ca or call our toll-free bilingual Cancer Information Service at 1-888-939-3333 (TTY 1-866-786-3934).
SOURCE: Canadian Cancer Society (Ontario Division)
For further information:
Christine Koserski, Communications Specialist
Canadian Cancer Society, Ontario Division